Research Frontiers Inc: Form 10-Q for the period ended Sep 30, 2022
Filed with the SEC on Nov 3, 2022 and accepted by EDGAR at Nov 3, 2022, 16:01 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2022-07-01 to 2022-09-30 | $150.4k | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2022-01-01 to 2022-09-30 | $409.8k | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Research and development | 3 months2022-07-01 to 2022-09-30 | $149.2k | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2022-01-01 to 2022-09-30 | $444.4k | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2022-07-01 to 2022-09-30 | −$486.2k | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2022-01-01 to 2022-09-30 | −$1.8m | us-gaap:OperatingIncomeLoss |
| Net income | 3 months2022-07-01 to 2022-09-30 | −$483.7k | us-gaap:NetIncomeLoss |
| Net income | 9 months2022-01-01 to 2022-09-30 | −$1.9m | us-gaap:NetIncomeLoss |
| Basic EPS | 3 months2022-07-01 to 2022-09-30 | −$0.02 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2022-01-01 to 2022-09-30 | −$0.06 | us-gaap:EarningsPerShareBasic |
| Operating cash flow | 9 months2022-01-01 to 2022-09-30 | −$1.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2022-01-01 to 2022-09-30 | $1.2k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2022-09-30 | $4.8m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2022-09-30 | $5.5m | us-gaap:AssetsCurrent |
| Total assets | At period end2022-09-30 | $6.0m | us-gaap:Assets |
| Current liabilities | At period end2022-09-30 | $267.7k | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2022-09-30 | $585.5k | us-gaap:Liabilities |
| Shareholders' equity | At period end2022-09-30 | $5.4m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001493152-22-030341. Last ingested by Listed: Oct 24, 2026, 14:57 ET. Listed shows no prices and gives no investment advice.